Amgen (AMGN) Stock
NASDAQ · AMGN
385.65
Fundamentals
Market cap
$208.49B
Price / Earnings ratio
23.5x
Price / Sales ratio
5.4x
Price / Book ratio
17.6x
Return on assets
0.1%
Ex-Dividend date
21 Aug 2026
Last payment date
N/A
Dividend amount
$2.52
Dividend yield
2.6%
Debt / Equity ratio
N/A
Latest news
About Amgen
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives.
SectorHealthcare
IndustryDrug Manufacturers - General
Employees31,500
CEOMr. Robert A. Bradway
IPO DateJun 17, 1983
HeadquartersThousand Oaks, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Robert A. Bradway | Chairman & CEO | 1963 |
| Mr. Murdo Gordon | Executive Vice President of Global Markets and Policy | 1967 |
Fundamentals
Valuation
Market cap$208.49B
Price-to-sales ratio5.39
Price-to-book value17.57
Price-earnings ratio23.50
Return on Equity89.00%
Return on Sales0.32%
Return on Assets0.09%
PEG ratio2.27
Earnings Per Share
Earnings Per Share$16.22
Income Statement
Average volume2,610,466
EBITDA$16.67B
1 year high (52w)$447.03
1 year low (52w)$269.77
Dividend
Ex dividend date21 Aug 2026
Dividend amount$2.52
Dividend yield2.58%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



